Immune-Onc\u516c\u53f8\u4e8e2016\u5e74\u6210\u7acb\u4e8e\u7f8e\u56fd\u7845\u8c37\uff0c\u6709\u5168\u7403\u9876\u5c16\u7684\u6838\u5fc3\u56e2\u961f\u3002\u836f\u7269\u5f00\u53d1\u4e0e\u8f6c\u5316\u7814\u7a76\u5b9e\u529b\u96c4\u539a\u3002\u56e2\u961f\u6838\u5fc3\u6210\u5458\u5747\u5728\u8de8\u56fd\u5927\u836f\u4f01\u6709\u591a\u5e74\u65b0\u836f\u7814\u53d1\u7ecf\u9a8c\uff0c\u66fe\u4e3b\u5bfc PD-L1 \u6297\u4f53Tecentriq \u7b49\u660e\u661f\u836f\u7269\u7684\u5f00\u53d1\uff0c\u4e3b\u5bfc\u6216\u53c2\u52a0\u7684NME\u9879\u76ee\u6a2a\u8de8\u4e34\u5e8a\u524d\u5230\u4e34\u5e8a\u53ca\u6ce8\u518c\u7533\u62a5\u7684\u836f\u7269\u5f00\u53d1\u5168\u6d41\u7a0b\u3002Co-founder \u5f20\u6210\u57ce\u535a\u58eb\u4e3a\u9876\u7ea7\u534e\u4eba\u79d1\u5b66\u5bb6\uff0c\u4f59\u56fd\u826f\u535a\u58eb\u4e3a\u51a0\u79d1\u7f8e\u535a\u3001Epitomics\u7684\u8054\u5408\u521b\u59cb\u4eba\u3002\u516c\u53f8\u4e0eUniversity of Texas\u3001\u7eaa\u5ff5\u65af\u9686-\u51ef\u7279\u7433\u764c\u75c7\u4e2d\u5fc3\u7b49\u591a\u5bb6\u9876\u7ea7\u5b66\u672f\u673a\u6784\u5bc6\u5207\u5408\u4f5c\uff0c\u57fa\u7840\u7814\u7a76\u80fd\u529b\u624e\u5b9e\uff0c\u79d1\u5b66\u987e\u95ee\u56e2\u961f\u7814\u7a76\u6210\u679c\u66fe\u520a\u53d1\u4e8e\u9876\u7ea7\u5b66\u672f\u671f\u520a\u5982 Nature, Cell\u3002<\/p>\n
\u6838\u5fc3\u7ba1\u7406\u5c42\u6709\u4e30\u5bcc\u7684\u836f\u7269\u5f00\u53d1\u7ecf\u9a8c\uff0c\u9876\u5c16\u7684\u836f\u7269\u5f00\u53d1\u548c\u5546\u4e1a\u5316\u987e\u95ee\u56e2\u961f\u4e3a\u516c\u53f8\u53d1\u5c55\u52a9\u529b\u3002\u56e2\u961f\u62e5\u6709\u7d2f\u8ba1\u8d85\u8fc760\u5e74\u7684\u836f\u7269\u5f00\u53d1\u7ecf\u9a8c\uff0c\u8d85\u8fc750\u4e2aIND\u7533\u8bf7\uff0c7\u4e2a\u6210\u529f\u7684\u539f\u521bBLAs\uff0c\u5305\u62ec\u4e09\u4e2a\u91cd\u78c5\u836f\u7269\uff0c\u7d2f\u8ba1\u53d1\u8868\u8d85\u8fc7120\u7bc7\u540c\u884c\u8bc4\u5ba1\u7684\u5b66\u672f\u8bba\u6587\uff0c\u5305\u62ecNature\u548cScience\u7b49\u9876\u7ea7\u5b66\u672f\u671f\u520a\u3002<\/p>\n
\u516c\u53f8\u6210\u7acb\u81f3\u4eca\u91c7\u53d6\u5faa\u5e8f\u6e10\u8fdb\u7684First-in-class\u7814\u53d1\u7b56\u7565\uff0c\u201c\u6b65\u6b65\u4e3a\u8425\u201d \u62d3\u5c55\u767e\u4ebf\u5e02\u573a\u3002LILRB4\u3001LILRB2\u3001LAIR1\u5747\u4e3a\u4e0e\u9ad3\u7ec6\u80de\u514d\u75ab\u6291\u5236\u76f8\u5173\u7684\u5168\u7403\u65b0\u9776\u70b9\uff0c\u516c\u53f8\u4ea7\u54c1\u5747\u4e3aFIC\u6216\u5177\u5907FIC\u6f5c\u529b\u7684\u521b\u65b0\u836f\u7269\u3002\u516c\u53f8\u9488\u5bf9LILRB4\u7684\u4ea7\u54c1\u5e03\u5c40\u4ee5\u9ad3\u7cfb\u767d\u8840\u75c5\u4e3a\u5feb\u901f\u4e0a\u5e02\u7b56\u7565\uff0c\u901a\u8fc7\u89e3\u9664\u9ad3\u7ec6\u80de\u514d\u75ab\u6291\u5236\u6cbb\u7597\u5b9e\u4f53\u7624\u4e3a\u5e02\u573a\u6269\u5f20\u7b56\u7565\uff0c\u5e76\u6709\u591a\u79cd\u4e0b\u4e00\u4ee3\u4ea7\u54c1\u62d3\u5c55\u5230\u8840\u6db2\u764c\u53caCAR-T\u7ec6\u80de\u6cbb\u7597\u3002\u516c\u53f8\u5728\u7814\u4ea7\u54c1\u5df2\u521d\u6b65\u8bc1\u5b9e\u5177\u5907\u5728\u591a\u79cd\u5b9e\u4f53\u7624\u4e2d\u7684\u5e94\u7528\u6f5c\u529b\uff0c\u6709\u671b\u6210\u4e3a\u201c\u9ad3\u7ec6\u80de\u4e2d\u7684anti-PD-1\u201d\u3002<\/p>\n
Immune-Onc \u5728\u7814\u4ea7\u54c1\u4e3a\u9488\u5bf9\u8840\u6db2\u7624\u548c\u5b9e\u4f53\u7624\u7684\u6297\u4f53\u836f\u7269<\/p><\/div>\n
\u516c\u53f8\u7684\u521b\u65b0\u80fd\u529b\u53d7\u5230\u5168\u7403\u4e00\u7ebf\u6295\u8d44\u673a\u6784\u7684\u8ba4\u53ef\uff0c\u5df2\u83b7\u5f97\u8d854000\u4e07\u7f8e\u5143\u878d\u8d44\uff0c\u6295\u8d44\u4eba\u5747\u4e3a\u56fd\u5185\u5916\u9876\u7ea7\u6295\u8d44\u673a\u6784\uff0c\u5982\u5317\u6781\u5149\u3001VIVO\u3001StartX\u3002\u516c\u53f8\u62e5\u6709\u5168\u7403\u9886\u5148\u7684 LILRB\u5bb6\u65cf\u836f\u7269\u7814\u53d1\u5e73\u53f0\u3002\u5728\u77ed\u77ed4\u5e74\u5df2\u6709\u4e00\u4e2aFIC\u4e34\u5e8a1\u671f\u4ea7\u54c1\uff0c\u4ee5\u53ca\u6570\u4e2a\u4e34\u5e8a\u524d\u4ea7\u54c1\u3002\u516c\u53f8\u4ea7\u54c1\u7ba1\u7ebf\u72ec\u7279\u65b0\u9896\uff0c\u7814\u53d1\u63a8\u8fdb\u6548\u7387\u53ca\u4ea7\u54c1\u5546\u4e1a\u5316\u524d\u666f\u83b7\u5f97\u4ea7\u4e1a\u4e0e\u8d44\u672c\u7684\u5e7f\u6cdb\u8ba4\u53ef\u3002\u73b0\u5df2\u5f00\u542f\u65b0\u4e00\u8f6e\u878d\u8d44\u7528\u4ee5\u516c\u53f8\u9886\u5148\u5728\u7814\u4ea7\u54c1\u7684\u4e34\u5e8a\u7814\u53d1\uff0c\u5982\u6709\u6295\u8d44\u6216\u5168\u7403\u5408\u4f5c\u610f\u5411\uff0c\u656c\u8bf7\u6d3d\u8be2\u4e50\u571f\u751f\u547d\u79d1\u6280\u516c\u53f8\uff0c\u90ae\u7bb1\uff1ainfo@cliventures.com\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"
\u4e50\u571f\u6d77\u5916\u6295\u8d44\u9879\u76ee\u4e4b\u4e00\uff0c\u5176\u9886\u5148\u5728\u7814\u4ea7\u54c1\u521b\u65b0\u764c\u75c7\u514d\u75ab\u7597\u6cd5IO-202\u7684\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\uff08IND\uff09\u4e8e\u4eca\u5e745\u6708\u83b7\u5f97\u7f8e\u56fdFDA\u6279\u51c6\uff0c\u76ee\u524d\u521a\u521a\u5f00\u542f\u65b0\u4e00\u8f6e\u878d\u8d44\u3002<\/p>\n","protected":false},"author":2,"featured_media":5717,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[4],"tags":[66],"acf":[],"yoast_head":"\n
\u4e50\u571f\u6295\u8d44\u7684\u5168\u65b0\u9776\u5411\u6297\u4f53\u836f\u516c\u53f8Immune-Onc\u5f00\u5c55\u65b0\u4e00\u8f6e\u878d\u8d44\u52a0\u5feb\u7814\u53d1\u4e34\u5e8a\u7ba1\u7ebf - \u4e50\u571f\u751f\u547d\u79d1\u6280<\/title>\n\n\n\n\n\n\n\n\n\n\n\n\t\n\t\n\t\n\n\n\n\t\n